Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): Its potential to reduce corticosteroids

Journal of Nephrology

Volumn 17, Issue SUPPL. 8, 2004, Pages

  Cantarovich, Diego ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Corticosteroid withdrawal; Kidney transplantation; Post transplant lymphoproliferative disorder; Simultaneous kidney pancreas transplantation; Thymoglobulin induction

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ACUTE GRAFT REJECTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; PANCREAS TRANSPLANTATION; REVIEW; ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; GRAFT REJECTION; MIDDLE AGED; PRESCHOOL CHILD; REOPERATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTILYMPHOCYTE SERUM; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PREDNISOLONE; REOPERATION;

EID: 16644377009     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Monaco AP. Antiserum to lymphocytes: Prolonged survival of canine allografts. Science 1966; 153: 1264-7.
2. Starzl TE. The use of heterologus agents in canine liver homotransplantation and in man renal homotransplantations. Surg Gynecol Obstet 1967; 124: 301-12.
3. Traeger J. Sérum antilymphocyte et transplantation rénale humaine. Méd Hyg 1967; 25: 754.
4. Hourmant M, Soulillou JP, Guenel J. Comparison of three immunosuppressive regimens in kidney transplantation: a single-centre randomised study. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985; 21: 982-6.
5. Hourmant M, Buzelin F, Dubigeon P, Soulillou JP. High long-term graft survival rates in kidney transplantation with the sequential association of antithymocyte globulin and cyclosporine A monotherapy. Transplant Proc 1987; 19: 2113-4.
6. Soulillou JP, Cantarovich D, Le Mauff B, Giral M, Robillard N, Hourmant M, Hirn M, Jacques Y. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts. N Engl J Med 1990; 322: 1175-82.
7. Cantarovich D, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Lerat L, Moreau A, Soulillou JP. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation. Nephrol Dial Transplant 2000; 15: 1673-6.
8. Cantarovich D, Paineau J, Karam G, Murat A, Baatard R, Dantal J, Hourmant M, Soulillou JP. Definitive corticosteroid withdrawal following simultaneous pancreas and kidney transplantation. Transplant Proc 1991; 23: 1583-4.
9. Cantarovich D, Karam G, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Le Normand L, Soulillou JP. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int 1998; 54: 1351-6.
10. Cantarovich D, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Karam G, Soulillou JP. Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of cortico-steroids: Results of a prospective pilot study in 28 consecutive cases. Transplantation 2000; 69: 1505-8.
11. Matas AJ, for the Steroid Withdrawal Study Group. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil. A prospective randomised study. Transplantation 1999; 68: 1865-74.
12. Vanrenterghem Y, Lebranchu Y, Hene R, Oppenheimer F, Ekberg H. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 1352-9.
13. Genestier G. Induction of fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 1998; 91: 2360-8.
14. Almawi WY, Hess DA, Assi JW, Chudzik DM, Rieder MJ. Pretreatment with glucocorticoids enhances T-cell effector function: possible implication for immune rebound accompanying glucocorticoid withdrawal. Cell Transplant 1999; 8: 637-47.
15. Monti P, Allavena P, Di Carlo V, Piemonti L. Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells. Int Immunopharmacol 2003; 3: 189-96.
16. Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998; 66: 1207-10.
17. Birkeland SA. Steroid-free immunosuppression in renal transplantation. Transplantation 2001; 71: 1089-90.
18. Cherikh WS, Kauffman HM, McBride MA, Maghirang J, Swinnen LJ, Hanto DW. Association of the type of induction immunosuppression with posttransplant lymphoproliferate disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation 2003; 76: 1289-93.
19. Goggins WC, Pascual MA, Powelson JA, Magee C, Tolkoff-Rubin N, Farrell ML, Ko DS, Williams WW, Chandraker A, Delmonico FL, Auchincloss H, Cosimi AB. A prospective, randomised, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003; 76: 798-802.
20. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, Revillard JP. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003; 75: 657-62.